HBK Sorce Advisory LLC grew its stake in shares of BlackRock Health Sciences Trust (NYSE:BME – Free Report) by 14.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,194 shares of the company’s stock after purchasing an additional 1,057 shares during the quarter. HBK Sorce Advisory LLC’s holdings in BlackRock Health Sciences Trust were worth $311,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of BME. Raymond James Financial Inc. acquired a new position in shares of BlackRock Health Sciences Trust during the fourth quarter worth about $3,250,000. Wolverine Asset Management LLC lifted its stake in shares of BlackRock Health Sciences Trust by 29.1% in the fourth quarter. Wolverine Asset Management LLC now owns 110,493 shares of the company’s stock worth $4,191,000 after acquiring an additional 24,928 shares in the last quarter. AlphaStar Capital Management LLC acquired a new position in shares of BlackRock Health Sciences Trust in the fourth quarter worth about $878,000. Hara Capital LLC acquired a new position in shares of BlackRock Health Sciences Trust in the fourth quarter worth about $832,000. Finally, Janney Montgomery Scott LLC lifted its stake in shares of BlackRock Health Sciences Trust by 40.5% in the fourth quarter. Janney Montgomery Scott LLC now owns 32,787 shares of the company’s stock worth $1,244,000 after acquiring an additional 9,455 shares in the last quarter.
BlackRock Health Sciences Trust Trading Down 0.1 %
NYSE:BME opened at $38.38 on Friday. BlackRock Health Sciences Trust has a one year low of $36.87 and a one year high of $42.64. The business’s 50-day simple moving average is $39.90 and its 200 day simple moving average is $40.22.
BlackRock Health Sciences Trust Dividend Announcement
About BlackRock Health Sciences Trust
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.
Read More
- Five stocks we like better than BlackRock Health Sciences Trust
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Buy Cheap Stocks Step by Step
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- Roth IRA Calculator: Calculate Your Potential Returns
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Want to see what other hedge funds are holding BME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Trust (NYSE:BME – Free Report).
Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.